About Guardant Health
Guardant Health is a company based in Redwood City (United States) founded in 2012.. Guardant Health has raised $557.5 million across 7 funding rounds from investors including Lightspeed Venture Partners, Khosla Ventures and Orbimed. The company has 2,020 employees as of December 31, 2024. Guardant Health has completed 2 acquisitions, including Bellwether Bio and Guardant Health AMEA. Guardant Health offers products and services including Shield Blood Test, Guardant Complete, and Guardant Infinity. Guardant Health operates in a competitive market with competitors including GRAIL, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Redwood City, United States
- Employees 2020 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Guardant Health, Inc.
-
Annual Revenue
$739.02 M31.04as on Dec 31, 2024
-
Net Profit
$-436.37 M8.98as on Dec 31, 2024
-
EBITDA
$-401.21 M22.79as on Dec 31, 2024
-
Total Equity Funding
$557.5 M (USD)
in 7 rounds
-
Latest Funding Round
$350 M (USD), Post-IPO
Nov 05, 2025
-
Investors
Lightspeed Venture Partners
& 12 more
-
Employee Count
2020
as on Dec 31, 2024
-
Investments & Acquisitions
Bellwether Bio
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Guardant Health
Guardant Health is a publicly listed company on the NASDAQ with ticker symbol GH in USA, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Guardant Health
Guardant Health offers a comprehensive portfolio of products and services, including Shield Blood Test, Guardant Complete, and Guardant Infinity. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Blood test for early detection of cancer in patients.
Genomic profiling test to guide cancer treatment options.
Platform for smart liquid biopsy in cancer therapies.
Unlock access to complete
Unlock access to complete
Leadership Team
27 people
Human Resources and Administration
12 people
Legal and Compliance
12 people
Finance and Accounting
11 people
Software Development Team
10 people
Operations Team
9 people
Senior Team
8 people
Product Management Team
6 people
Unlock access to complete
Funding Insights of Guardant Health
Guardant Health has successfully raised a total of $557.5M across 7 strategic funding rounds. The most recent funding activity was a Post-IPO round of $350 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Post-IPO — $350.0M
-
First Round
First Round
(14 Feb 2014)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Post-IPO - Guardant Health | Valuation |
investors |
|
| Nov, 2020 | Amount | Post-IPO - Guardant Health | Valuation |
investors |
|
| Aug, 2017 | Amount | Series E - Guardant Health | Valuation | SoftBank Vision Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Guardant Health
Guardant Health has secured backing from 13 investors, including venture fund and angel investors. Prominent investors backing the company include Lightspeed Venture Partners, Khosla Ventures and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Venture capital investing in innovative companies across global sectors is undertaken by Lightspeed Venture Partners.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Guardant Health
Guardant Health has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Bellwether Bio and Guardant Health AMEA. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
A technology platform for AI-driven cancer diagnosis is provided.
|
2018 | ||||
|
Cancer diagnostics are provided via cell-free DNA analysis.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Guardant Health
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Guardant Health Comparisons
Competitors of Guardant Health
Guardant Health operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GRAIL, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Guardant Health
Frequently Asked Questions about Guardant Health
When was Guardant Health founded?
Guardant Health was founded in 2012 and raised its 1st funding round 2 years after it was founded.
Where is Guardant Health located?
Guardant Health is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Who is the current CEO of Guardant Health?
Helmy Eltoukhy is the current CEO of Guardant Health.
Is Guardant Health a funded company?
Guardant Health is a funded company, having raised a total of $557.5M across 7 funding rounds to date. The company's 1st funding round was a Series E of $360M, raised on Feb 14, 2014.
How many employees does Guardant Health have?
As of Dec 31, 2024, the latest employee count at Guardant Health is 2,020.
What is the annual revenue of Guardant Health?
Annual revenue of Guardant Health is $739.02M as on Dec 31, 2024.
What does Guardant Health do?
Developer of digital sequencing technology for cancer detection. The product Guardant360 offers real-time, biopsy-free tumor sequencing for the analysis and identification of tumor-associated treatment options. Also, it has developed analytical tools, including a tumor response map and a mobile-enabled physician portal.
Who are the top competitors of Guardant Health?
Guardant Health's top competitors include GRAIL, Strand Life Sciences and Foundation Medicine.
What products or services does Guardant Health offer?
Guardant Health offers Shield Blood Test, Guardant Complete, and Guardant Infinity.
Is Guardant Health publicly traded?
Yes, Guardant Health is publicly traded on NASDAQ under the ticker symbol GH.
How many acquisitions has Guardant Health made?
Guardant Health has made 2 acquisitions, including Bellwether Bio, and Guardant Health AMEA.
Who are Guardant Health's investors?
Guardant Health has 13 investors. Key investors include Lightspeed Venture Partners, Khosla Ventures, Orbimed, Pear VC, and SoftBank Vision Fund.
What is Guardant Health's ticker symbol?
The ticker symbol of Guardant Health is GH on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.